Antitumor mechanisms of OncoTherad nano- immunotherapy involving toll-like 4 recep...
New Therapeutic Approaches for Non-Muscle Invasive Bladder Cancer (NMIBC): Intrave...
Therapeutic and toxicological effects of OncoTherad (MRB-CFI-1) immunotherapy in p...
Effects of OncoTherad immunotherapy (MRB-CFI-1) on tumor progression and survival ...
Association of immunotherapy with OncoTherad® (MRB-CFI-1) and erythropoietin in th...
Association of immunotherapy with OncoTherad® (MRB-CFI-1) and platelet rich plasma...
Clinical Implications Among Immune Response, Immune Checkpoints, Monoamine Oxidase...